Skip to content

Special Drug Use-results Survey for Long-term Administration of Tramcet Combination Tablets

Special Drug Use-results Survey for Long-term Administration of Tramcet Combination Tablets - Special Drug Use-results Survey for Long-term Administration of Tramcet Combination Tablets

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000015901
Enrollment
1200
Registered
2014-12-15
Start date
2011-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain

Interventions

None listed

Sponsors

Janssen Pharmaceutical K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic pain who are treated with Tramcet Combination Tablet for the first time

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Safety (Adverse Drug Reaction) Effectiveness (Efficacy)

Secondary

MeasureTime frame
Effectiveness (NRS)

Countries

Japan

Contacts

Public ContactHirokazu Shirai

Janssen Pharmaceutical K.K. Safety Risk Management Dept

hshirai3@ITS.JNJ.com03-4411-5951

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026